An Unusual Cause of Dysphagia with Bronchoesophageal Fistula

Slides:

Advertisements

Similar presentations

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Advertisements

Inflammatory Myofibroblastic Tumor of the Left Main Stem Bronchus

Lung Cancer with Unusual Presentation as a Thin-Walled Cyst in a Young Nonsmoker Chou-Chin Lan, MD, Hong-Cheng Wu, MD, Chih-Hsin Lee, MD, Shiu-Feng Huang,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD Journal of Thoracic Oncology

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib Nobukazu Agatsuma, MD Journal of.

Lungs on Fire Journal of Thoracic Oncology

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib Nobukazu Agatsuma, MD Journal of.

Pulmonary Hydatid Cyst Mimicking a Lung Cancer

Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient Jong Sik Lee, MD, Jae Young Hur, PhD,

Sclerosing Pneumocytoma with Lymph Node Metastasis

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Rapidly Progressive Diffuse Cystic Lesions as a Radiological Hallmark of Lung Adenocarcinoma Jian Zhang, MD, Yi-Lin Zhao, MD, Ming-Xiang Ye, MD, Gang.

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma Taylor M.

Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD

Electronic Updates for JTO Readers

An Aortoesophageal Fistula in Patient with Lung Cancer after Chemo-Irradiation and Subsequent Esophageal Stent Implantation Soo-Jung Um, MD, Byeong Ho.

Primary Non-Hodgkin's Lymphoma of the Trachea

An Unusual Presentation of Malignant Pleural Mesothelioma

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.

Intravascular Lymphoma as a Cause of Respiratory Failure

Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First- line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor.

Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP

A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib Parneet K. Cheema, MD, MBiotech, FRCPC Journal.

Histologic Transformation in NSCLC with PD-1 therapy

Lung Metastases from Esophageal Granular Cell Tumor: An Undoubted Criterion for Malignancy Isidro Machado, MD, PhD, Julia Cruz, MD, PhD, Estanislao Arana,

Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review Arianna Casagrande, MD, Federica Pederiva,

Ritbune Prakobkit, MD, William Churk-Nam Auyeung, MD

Elizabeth B. Gottlin, PhD, Rex C. Bentley, MD, Michael J

Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature Caicun Zhou, MD, PhD, Luan Di Yao, MD

Multiple Organ Mucosa-Associated Lymphoid Tissue Lymphoma Presenting with Lymphangitic Pattern of Spread in the Lung Satoshi Kohmo, MD, Isao Tachibana,

Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib Shiro Fujita, MD, PhD, Katsuhiro Masago, MD, PhD, Nobuyuki Katakami, MD, PhD,

Solitary Choriocarcinoma in the Lung

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

A Case of Pleural Epithelioid Sarcoma of Proximal Type Presenting as Malignant Pleural Mesothelioma Gitte Anna Madsen, MD, Torben Riis Rasmussen, MD,

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib Yoon Jin Cha, MD, PhD, Byoung Chul.

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Vamsidhar Velcheti, MD Journal of Thoracic Oncology

The Role of Surgery in the Management of Primary Thymic Mucosa-associated Lymphoid Tissue (MALT) Lymphoma Kimihiro Shimizu, MD, PhD, Izumi Takeyoshi,

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers Jules L. Derks, MD Journal of.

A Primer on Health Economic Evaluations in Thoracic Oncology

Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma Naoyuki.

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer Allison Ackerman, MD, Michael A. Goldstein,

Nivolumab-Induced Granulomatous Inflammation of the Pleura

Anu Dham, MD, Alexander M. Truskinovsky, MD, Arkadiusz Z

A Rare Case of Endobronchial Amelanotic Melanoma

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Transvenous Metastasis to the Heart

Concomitant Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion in a Patient with Multifocal Lung Adenocarcinomas Jun Fan, MD Journal of Thoracic.

Large Bronchopleural Fistula After Surgical Resection: Secret to Success Isabelle Delanote, MD, Werner Budts, MD, PhD, Paul De Leyn, MD, PhD, Christophe.

European Lung Cancer Conference (ELCC) 2016 Organisation

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Metastatic Lung Cancer to the Pancreas

Nonintubated thoracoscopic surgery for pulmonary lesions in both lungs

Collaterals Journal of Thoracic Oncology

Journal of Thoracic Oncology

David Garfield, MD Journal of Thoracic Oncology

Popcorn in the Lung Journal of Thoracic Oncology

Thymic Small Cell Carcinoma Shows Marked Response to Amrubicin

A Review of First-Line Treatment for Small-cell Lung Cancer

Robert Comis, MD, The Passing of a “Lung Man”

Lung Cancer with Unusual Presentation as a Thin-Walled Cyst in a Young Nonsmoker Chou-Chin Lan, MD, Hong-Cheng Wu, MD, Chih-Hsin Lee, MD, Shiu-Feng Huang,

Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues” Boris Sepesi,

Presentation transcript:

An Unusual Cause of Dysphagia with Bronchoesophageal Fistula Rita Vale Rodrigues, MD, Sara Ferreira, MD, António Dias Pereira, MD, PhD Journal of Thoracic Oncology Volume 11, Issue 9, Pages 1591-1593 (September 2016) DOI: 10.1016/j.jtho.2016.05.033 Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Upper endoscopy: obstructive neoplasm in the midesophagus. Journal of Thoracic Oncology 2016 11, 1591-1593DOI: (10.1016/j.jtho.2016.05.033) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 Chest computed tomography: peribronchial mass, 108 mm in the greatest dimension, with bronchoesophageal fistula. NGT, nasogastric tube. Journal of Thoracic Oncology 2016 11, 1591-1593DOI: (10.1016/j.jtho.2016.05.033) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 3 Upper endoscopy: esophageal lesion and extensive tracheobronchial destruction forming a large necrotic cavity in the mediastinum. Journal of Thoracic Oncology 2016 11, 1591-1593DOI: (10.1016/j.jtho.2016.05.033) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

Figure 4 Diffuse large B-cell lymphoma: (A) large lymphocytes with a diffuse growth pattern (hematolylin and eosin; original magnification, ×10), (B) large lymphocytes with a diffuse growth pattern (hematolylin and eosin; original magnification, ×40), (C) negative immunostaining for cytokeratin AE1, cytokeratin AE3 (original magnification, ×40), (D) negative immunostaining for cluster of differentiation 3 (x20), (E) positive immunostaining for CD20 (×40), and (F) Ki67 positive in 80% of cells (×20). Journal of Thoracic Oncology 2016 11, 1591-1593DOI: (10.1016/j.jtho.2016.05.033) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions